ROSEN, SKILLED INVESTOR COUNSEL, Encourages Anavex Life Sciences Corp. Investors to Inquire About Securities Class Action Investigation – AVXL – QNT Press Release


NEW YORK, Feb. 12, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Anavex Life Sciences Corp. (NASDAQ:AVXL) resulting from allegations that Anavex may have issued materially misleading business information to the investing public.

SO WHAT: If you purchased Anavex securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses.

WHAT TO DO NEXT: To join the prospective class action, go to or call Phillip Kim, Esq. toll-free at 866-767-3653 or email or for information on the class action.

WHAT IS THIS ABOUT: On February 1, 2022, before…

Full story available on


Source link

Recommended For You

About the Author: News Center